Iron Measured in Nasal Exudate Samples as a New and Useful Biomarker in the Differential Diagnosis of Patients with Acute Stroke
- 1 December 2020
- journal article
- research article
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 49 (6), 625-631
- https://doi.org/10.1159/000511395
Abstract
Introduction: Differential diagnosis between ischemic and hemorrhagic strokes in the acute stage is one of the major challenges of neurovascular research. Several biomarkers have been studied, but attempts to date have focused on determining their blood levels. Recently, cerebral lymphatic drainage toward the nostrils has been discovered, giving us the chance to study nasal exudate looking for biomarkers of neural damage. We sought to confirm whether iron levels in nasal exudate could identify the hemorrhagic nature of acute stroke. Methods: We studied iron nasal exudate levels in 32 ischemic and 43 hemorrhagic stroke patients. All patients underwent neurological examination assessed by the National Institutes of Health Stroke Scale (NIHSS), brain computed tomography to the differential diagnosis of stroke subtype, laboratory tests, and measurement of iron levels in nasal exudate. Results: The iron levels in nasal exudate were higher in hemorrhagic stroke patients. The area under the receiver operating characteristic curve for ischemic/hemorrhagic stroke discrimination was 0.896 (95% confidence interval 0.823-0.970) and cutoff point of 0.078 nmol/mg (sensitivity 93%, specificity 73%). Conclusions: Our findings suggest that iron levels in nasal exudate may be useful in the acute stage for the differential diagnosis between ischemic and hemorrhagic damage in acute stroke patients. They also open a potential field to study other biomarkers in nasal exudate in several neurological disorders. Clinical studies must be performed to confirm our results.This publication has 21 references indexed in Scilit:
- Iron overload, measured as serum ferritin, increases brain damage induced by focal ischemia and early reperfusionNeurochemistry International, 2012
- Serum biomarkers of spontaneous intracerebral hemorrhage induced secondary brain injuryJournal of the Neurological Sciences, 2012
- Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: The S100B/RAGE pathwayJournal of Proteomics, 2012
- Biomarker level improves the diagnosis of embolic source in ischemic stroke of unknown originZeitschrift für Neurologie, 2012
- The Use of Blood Biomarkers to Predict Poor Outcome After Acute Transient Ischemic Attack or Ischemic StrokeStroke, 2012
- The serum ferritin level is an important predictor of hemorrhagic transformation in acute ischaemic strokeEuropean Journal of Neurology, 2011
- Iron-Related Brain Damage in Patients With Intracerebral HemorrhageStroke, 2010
- Translation of Neurological Biomarkers to Clinically Relevant PlatformsMethods in molecular biology (Clifton, N.J.), 2009
- What is the blood–brain barrier (not)?Trends in Immunology, 2007
- Iron and Iron-Handling Proteins in the Brain After Intracerebral HemorrhageStroke, 2003